JNJ stock reporting earnings, expecting $2 EPS and $22.44B revenue, approval for Spravato, mixed chart signals, $167.71 price ...

Emergent BioSolutions operates as a life sciences company that offers a Narcan Nasal Spray for opioid overdose ... of 2.23 for the Specialty & Generic Drug Manufacturing industry.

Overdose deaths in Whatcom County soared from 91 in 2022 to 137 in 2023, fueled by cheap and easily available drugs — ...

Calculating a bolus dose is where insulin administration can ... a glucagon emergency kit on hand at all times. It’s a nasal spray or injection that treats severe hypoglycemia.

Data: San Diego County Medical Examiner's Office; Chart: Axios Visuals The big picture ... availability and affordability of naloxone, a nasal spray medication that reverses opioid overdoses ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...